Content about Antiretroviral drug

January 15, 2013

Switching to multi-pill generic HIV treatment could diminish effectiveness, study finds

While replacing a single combination pill for HIV with generics would save the healthcare system money, it could also diminish the effectiveness of treatment, a new study suggests.

January 2, 2013

First anti-diarrheal drug for HIV/AIDS patients receives FDA approval

The U.S. Food and Drug Administration on Monday approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of medicines used to treat HIV infection.

September 5, 2012

FDA delays action on Salix drug

The Food and Drug Administration will not decide whether to approve a drug for diarrhea in HIV patients as it continues to review the regulatory approval application for it, the drug's manufacturer said.

July 9, 2012

Community pharmacies could have advantage in HIV

After it was first identified as the cause of AIDS in 1983, being diagnosed with an HIV infection was a literal death sentence, and it remains that way for many people in poor countries who lack access to the life-saving medications that have transformed HIV from a sure ticket to death into a chronic illness.

May 9, 2012

Reports: FDA may be close to approving drug for HIV prevention

The Food and Drug Administration may be close to approving a drug for preventing HIV infection, according to published reports.

February 14, 2012

FDA grants priority review to Gilead's Truvada for HIV prevention

The Food and Drug Administration is giving priority review to a drug made by Gilead Sciences that the company is investigating for the prevention of HIV.

May 24, 2011

Report: States scale back funding to HIV, AIDS medication programs

Several states are cutting funding to programs that provide HIV medications to people who can’t afford them in an effort to reduce spending, according to a published report.

May 12, 2011

Study: Antiretroviral therapy cuts HIV transmission risk by 96%

Patients with HIV who immediately started antiretroviral therapy significantly reduced the risk of spreading the virus to an uninfected partner, compared with those who delayed therapy, according to results of a multinational study. The study also found that antiretroviral therapy reduced the risk of transmission by 96%.

January 27, 2011

Matrix obtains license agreement for HIV treatment

A Mylan subsidiary has inked a nonexclusive license agreement with Tibotec Pharmaceuticals to manufacture, market and distribute a generic version of an HIV treatment.

January 5, 2010

Adherence to HIV therapy may cut healthcare costs, study finds

Increased adherence of HIV therapy may be cost-effective, according to a new study....